Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases

MF Rasool, S Ali, S Khalid, R Khalid, A Majeed… - Scientific Reports, 2021 - nature.com
… The developed disease models were successful in predicting captopril PK … parameters
were in close agreement. The developed captopril PBPK models can assist in tailoring captopril

Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease

S Khalid, MF Rasool, I Masood, I Imran, H Saeed… - Scientific Reports, 2023 - nature.com
… -disease model of captopril 32 was scaled to the pediatric population for estimating captopril
ADME in children with renal impairment. The study aimed to predict captopril PK in children …

Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension

LEJ Peeters, MP Kester, L Feyz… - Expert Opinion on …, 2019 - Taylor & Francis
It is more prevalent in the elderly population. Recently updated American and European
guidelines recommend treating every elderly patient with hypertension independent of age, …

[HTML][HTML] Captopril and Hydrochlorothiazide: Insights on Pharmacology and Analytical Chemistry Profile

MM Sebaiy, KM Hegazy… - … of Chemistry & its …, 2022 - onlinescientificresearch.com
… Many categories of drugs are used today for hypertension such as captopril which belongs
to ACE inhibitors family and hydrochlorothiazide which consider a diuretic drug.In this …

[HTML][HTML] Clinical pharmacokinetics of enalapril and enalaprilat in pediatric patients—A systematic review

M Faisal, W Cawello, S Laeer… - Frontiers in …, 2021 - frontiersin.org
… the first-line treatment in pediatric heart failure and is together with captopril the most widely
… were informative in terms of the pharmacokinetic parameters, enalapril concentrations in the …

An up-to-date article regarding particularities of drug treatment in patients with chronic heart failure

V Buda, A Prelipcean, D Cozma, DE Man… - Journal of clinical …, 2022 - mdpi.com
… regarding pharmacological treatment (including new approaches in HF treatment strategies
[… sex differences) and treatment (pharmacokinetic and pharmacodynamic changes in drugs; …

Antihypertensive drug classes

EAH Algharably, R Kreutz - Manual of Hypertension of the …, 2019 - taylorfrancis.com
… dosing is usually sufficient for BP control except for captopril (requiring at least 2–3 doses
per … Table 40.2 Pharmacokinetic characteristics and dosage of selected angiotensin receptor …

Pharmacokinetics/Pharmacodynamics and Sex Differences

S Yoon - Sex/Gender-Specific Medicine in Clinical Areas, 2024 - Springer
… include verapamil, captopril, felodipine, and … it does exhibit a protective effect against stroke
[39,40,41]. These sex differences may be attributed to the distinct pharmacokinetic properties

The Role of Polymers and Excipients for Better Gastric Retention of Captopril

U Das, P Wadhwa, PK Singh… - … ™ in Therapeutic …, 2022 - dl.begellhouse.com
… can improve the pharmacodynamic and pharmacokinetic properties of biopharmaceuticals.…
Gastro-retentive drug delivery systems and their in vivo success: A recent update. Asian J …

Pharmacology of antihypertensive drugs

J Elliott, L Pelligand - Hypertension in the Dog and Cat, 2020 - Springer
… studied, and captopril was the first … Captopril possesses a sulphydryl group which forms an
ionic bond with the zinc atom. Unfortunately, although a very effective ACE inhibitor, captopril